SMAD3 and astrocytoma (excluding glioblastoma): Compared to G2 tumors, high-grade astrocytomas (G3 and G4) exhibited elevated levels of SKIL, SMAD1, SMAD3, BMP2, and MAPK1, with most differences reaching statistical significance (p < 0.05).